nivolumab and ipilimumab combination in frontline mcrc
Published 5 years ago • 165 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:11
nivolumab/ipilimumab combination data promising in msi-h/dmmr mcrc
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
5:19
i-o therapy in mcrc: ipilimumab nivolumab
-
3:49
mcrc: combination therapy and testing
-
1:43
nivolumab, ipilimumab and panitumumab in mcrc
-
2:15
dr. lenz discusses frontline nivolumab plus ipilimumab in mcrc
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
5:59
nivolumab plus low-dose ipilimumab promising for treatment-naïve msi-high mcrc | heinz-josef lenz
-
4:31
checkmate142: checkpoint combination therapy in first-line colorectal cancer
-
2:37
moving forward with results from checkmate-142 in msi-h mcrc
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
5:37
nivolumab plus ipilimumab improves on chemo in previously untreated msi-h/dmmr mcrc
-
1:26
dr. andre on nivolumab plus ipilimumab in dmmr/msi-h mcrc
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
4:20
frontline treatment for kras wild-type mcrc
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
1:26
longterm benefits from nivolumab and ipilimumab combination therapy
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc